Scenesse (afamelanotide) for adults with a history of phototoxic ...
SCENESSE ® (afamelanotide) implant is a prescription medication indicated to increase pain-free light exposure in adult patients with a history of phototoxic reactions from erythropoietic …
About SCENESSE® - SCENESSE® (Afamelanotide)
SCENESSE ® (pronounced “sen-esse”) acts by increasing the levels of eumelanin in the skin, shielding against UV radiation (UVR) and visible light, including sunlight. Afamelanotide is a …
SCENESSE is a melanocortin 1 receptor (MC1-R) agonist indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic …
About Erythropoietic Protoporphyria - SCENESSE® (Afamelanotide)
General information about the safe and effective use of SCENESSE ®: Sun protection Please maintain sun and light protection measures during treatment with SCENESSE ® to prevent …
Safety and Efficacy Data - SCENESSE® (Afamelanotide)
The safety of SCENESSE ® was evaluated in 3 randomized, multicenter, prospective, vehicle controlled clinical trials (Study CUV029, Study CUV030, and Study CUV039) involving 244 …
EPP Centers - SCENESSE® (Afamelanotide)
General information about the safe and effective use of SCENESSE ®: Sun protection Please maintain sun and light protection measures during treatment with SCENESSE ® to prevent …
SCENESSE is a melanocortin 1 receptor (MC1-R) agonist indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic …
Contact Us - SCENESSE® (Afamelanotide)
To stay up to date on news about SCENESSE® and EPP, subscribe to our mailing list or send us an enquiry.
Stay Updated - SCENESSE® (Afamelanotide)
Before receiving SCENESSE ® you should tell your doctor: if you are taking, have recently taken or might take any other medicines. if you are taking anticoagulant medicines used to prevent …